Senior insider sale
President, Head of R&D at SYNDAX PHARMACEUTICALS INC — senior position signals high conviction
$71.6K
4.62K shares
What this filing means
GALLAGHER NEIL plans to sell 4.62K shares of SYNDAX PHARMACEUTICALS INC valued at approximately $71.6K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/10/2025ACC: 0001959173-25-000833
Officer· President, Head of R&D
Since Apr 2023
4.62K
Shares to sell
$71.6K
Approx. market value
4.62K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
2/7/2025
4.62KTotal acquired4.62K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/7/2025 | Restricted Stock Vesting Compensation | 4.62K | — |
| Total | 4.62K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
4.62K
Market value
$71.6K
2/10/2025
Total
Units
4.62K
Value
$71.6K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
2/10/2025 | 4.62K | $71.6K | NASDAQ | Planned |
| Total | 4.62K | $71.6K | ||